NECLIFE
Start SIP
Invest Now
Start SIP in NECLIFE
Nectar Lifesciences live price: ₹11.09. It opened at ₹11 vs previous close ₹11; intraday high/low: ₹11/₹11. The 50 & 200 DMA stand at ₹13.61/₹17.57.
Nectar Lifesciences Performance
- Low
- ₹11
- High
- ₹11
- 52 Week Low
- ₹11
- 52 Week High
- ₹28
- Open Price₹11
- Previous Close₹11
- Volume450,527
- 50 DMA₹13.61
- 100 DMA₹15.02
- 200 DMA₹17.57
Investment Returns
- Over 1 Month -17.24%
- Over 3 Month -47.19%
- Over 6 Month -33.03%
- Over 1 Year -53.38%
Smart Investing Starts Here Start SIP with Nectar Lifesciences for Steady Growth!
Nectar Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -0.7
- PEG Ratio
- 0
- Market Cap Cr
- 249
- P/B Ratio
- 0.3
- Average True Range
- 0.53
- EPS
- 0
- Dividend Yield
- 0
- MACD Signal
- -0.83
- RSI
- 22.61
- MFI
- 12.1
Nectar Lifesciences Financials
Nectar Lifesciences Technicals
EMA & SMA
Current Price
₹11.09
0
(0%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹12.06
- 50 Day
- ₹13.61
- 100 Day
- ₹15.02
- 200 Day
- ₹17.57
Resistance and Support
11.17
- R3 11.96
- R2 11.72
- R1 11.41
- S1 10.86
- S2 10.62
- S3 10.31
Nectar Lifesciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-23 | Quarterly Results & Others | To consider other business matters. |
| 2025-11-14 | Quarterly Results | |
| 2025-08-14 | Quarterly Results & Others | To consider other business matters. |
| 2025-07-23 | Others | Inter alia amongst other items, the mode of rewarding of shareholders as contemplated in the explanatory statement to item no. 3 of Notice of 2025-26/01st EGM or matters related thereto. |
| 2025-07-07 | Audited Results |
Nectar Lifesciences F&O
About Nectar Lifesciences
- NSE Symbol
- NECLIFE
- BSE Symbol
- 532649
- Chairman & Managing Director
- Mr. Sanjiv Goyal
- ISIN
- INE023H01027
Similar Stocks to Nectar Lifesciences
Nectar Lifesciences FAQs
Nectar Lifesciences share price is ₹11 As on 17 March, 2026 | 04:12
The Market Cap of Nectar Lifesciences is ₹248.7 Cr As on 17 March, 2026 | 04:12
The P/E ratio of Nectar Lifesciences is -0.7 As on 17 March, 2026 | 04:12
The PB ratio of Nectar Lifesciences is 0.3 As on 17 March, 2026 | 04:12
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.